Novartis Pharma Stein AG (manufacturing, quality control (excluding bioanalysis), primary packaging, secondary packaging)
UkraineAll drugs from this manufacturer
-
The drug is prescribed for the treatment of periodic fever syndromes (CAP syndrome, TRAP syndrome, HID syndrome/MKD, familial Mediterranean fever), Still's disease (in adults and children), and for the symptomatic treatment of frequent attacks of gouty arthritis in adults.
Dosage form: solution for injection
Active substance Dosage canakinumab 150 mg/ml ATC: L04AC08